Brief: 4Basebio Says Working With Universities To Develop Treatment For Neurofibromatosis Type 1
10/06/2022 07:46
June 10 (Reuters) - 4Basebio PLC 4BB.L :
* 4BASEBIO: COLLABORATION WITH UNIVERSITY OF ALABAMA &
TEESSIDE
UNIVERSITY IN RESEARCH PROJECT AIMED TO DEVELOP TREATMENT FOR
NEUROFIBROMATOSIS TYPE 1
Source text for Eikon: ID:nPRr94712a
Further company coverage: 4BB.L
((Reuters.Briefs@thomsonreuters.com;))